Three-dimensional heads-up system assisted pars plana vitrectomy and subretinal recombinant tissue plasminogen activator injection for submacular hemorrhage

Glatt H, Machemer R. Experimental subretinal hemorrhage in rabbits. Am J Ophthalmol. 1982;94(6):762–73.

Article  CAS  Google Scholar 

Toth CA, Morse LS, Hjelmeland LM, Landers MB 3rd. Fibrin directs early retinal damage after experimental subretinal hemorrhage. Arch Ophthalmol. 1991;109(5):723–9.

Article  CAS  Google Scholar 

Hattenbach LO, Klais C, Koch FH, Gümbel HO. Intravitreous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditions. Ophthalmology. 2001;108(8):1485–92.

Article  CAS  Google Scholar 

Avery RL, Fekrat S, Hawkins BS, Bressler NM. Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration. Retina. 1996;16(3):183–9.

Article  CAS  Google Scholar 

Saito-Uchida S, Inoue M, Koto T, Kato Y, Hirakata A. Vitrectomy combined with subretinal injection of tissue plasminogen activator for successful treatment of massive subretinal hemorrhage. Eur J Ophthalmol. 2021;31(5):2588–95.

Article  Google Scholar 

Kimura S, Morizane Y, Hosokawa MM, Shiode Y, Doi S, Hosogi M, et al. Outcomes of vitrectomy combined with subretinal tissue plasminogen activator injection for submacular hemorrhage associated with polypoidal choroidal vasculopathy. Jpn J Ophthalmol. 2019;63(5):382–8.

Article  CAS  Google Scholar 

Kimura S, Morizane Y, Matoba R, Hosokawa M, Shiode Y, Hirano M, et al. Retinal sensitivity after displacement of submacular hemorrhage due to polypoidal choroidal vasculopathy: effectiveness and safety of subretinal tissue plasminogen activator. Jpn J Ophthalmol. 2017;61(6):472–8.

Article  CAS  Google Scholar 

Eckardt C, Paulo EB. Heads-up surgery for vitreoretinal procedures: an experimental and clinical study. Retina. 2016;36(1):137–47.

Article  Google Scholar 

Wang K, Song F, Zhang L, Xu J, Zhong Y, Lu B, et al. Three-dimensional heads-up cataract surgery using femtosecond laser: efficiency, efficacy, safety, and medical education-a randomized clinical trial. Transl Vis Sci Technol. 2021;10(9):4.

Article  CAS  Google Scholar 

Romano MR, Cennamo G, Comune C, Cennamo M, Ferrara M, Rombetto L, et al. Evaluation of 3D heads-up vitrectomy: outcomes of psychometric skills testing and surgeon satisfaction. Eye (Lond). 2018;32(6):1093–8.

Article  Google Scholar 

Coppola M, La Spina C, Rabiolo A, Querques G, Bandello F. Heads-up 3D vision system for retinal detachment surgery. Int J Retina Vitreous. 2017;3:46.

Article  Google Scholar 

Chhaya N, Helmy O, Piri N, Palacio A, Schaal S. Comparison of 2D and 3D video displays for teaching vitreoretinal surgery. Retina. 2018;38(8):1556–61.

Article  Google Scholar 

Rizzo S, Abbruzzese G, Savastano A, Giansanti F, Caporossi T, Barca F, et al. 3D Surgical viewing system in ophthalmology: perceptions of the surgical team. Retina. 2018;38(4):857–61.

Article  Google Scholar 

Zhao XY, Zhao Q, Li NN, Meng LH, Zhang WF, Wang EQ, et al. Surgery-related characteristics, efficacy, safety and surgical team satisfaction of three-dimensional heads-up system versus traditional microscopic equipment for various vitreoretinal diseases. Graefes Arch Clin Exp Ophthalmol. 2022. https://doi.org/10.1007/s00417-022-05850-z.

Article  Google Scholar 

Sakamoto T, Sheu SJ, Arimura N, Sameshima S, Shimura M, Uemura A, et al. Vitrectomy for exudative age-related macular degeneration with vitreous hemorrhage. Retina. 2010;30(6):856–64.

Article  Google Scholar 

Benner JD, Morse LS, Toth CA, Landers MB 3rd, Hjelmeland LM. Evaluation of a commercial recombinant tissue-type plasminogen activator preparation in the subretinal space of the cat. Arch Ophthalmol. 1991;109(12):1731–6.

Article  CAS  Google Scholar 

Hillenkamp J, Surguch V, Framme C, Gabel VP, Sachs HG. Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator. Graefes Arch Clin Exp Ophthalmol. 2010;248(1):5–11.

Article  CAS  Google Scholar 

Tiew S, Lim C, Sivagnanasithiyar T. Using an excel spreadsheet to convert Snellen visual acuity to LogMAR visual acuity. Eye (Lond). 2020;34(11):2148–9.

Article  Google Scholar 

Schulze-Bonsel K, Feltgen N, Burau H, Hansen L, Bach M. Visual acuities “hand motion” and “counting fingers” can be quantified with the freiburg visual acuity test. Invest Ophthalmol Vis Sci. 2006;47(3):1236–40.

Article  Google Scholar 

Irigoyen C, Amenabar Alonso A, Sanchez-Molina J, Rodríguez-Hidalgo M, Lara-López A, Ruiz-Ederra J. Subretinal injection techniques for retinal disease: a review. J Clin Med. 2022;11(16):4717.

Article  CAS  Google Scholar 

Candiello J, Cole GJ, Halfter W. Age-dependent changes in the structure, composition and biophysical properties of a human basement membrane. Matrix Biol. 2010;29(5):402–10.

Article  CAS  Google Scholar 

Haritoglou C, Mauell S, Benoit M, Schumann RG, Henrich PB, Wolf A, et al. Vital dyes increase the rigidity of the internal limiting membrane. Eye (Lond). 2013;27(11):1308–15.

Article  CAS  Google Scholar 

Okanouchi T, Toshima S, Kimura S, Morizane Y, Shiraga F. Novel technique for subretinal injection using local removal of the internal limiting membrane. Retina. 2016;36(5):1035–8.

Article  Google Scholar 

Malik FF, Poulaki V. Management of submacular hemorrhage. Int Ophthalmol Clin. 2014;54(2):51–9.

Article  Google Scholar 

Tranos P, Tsiropoulos GN, Koronis S, Vakalis A, Asteriadis S, Stavrakas P. Comparison of subretinal versus intravitreal injection of recombinant tissue plasminogen activator with gas for submacular hemorrhage secondary to wet age-related macular degeneration: treatment outcomes and brief literature review. Int Ophthalmol. 2021;41(12):4037–46.

Article  Google Scholar 

de Jong JH, van Zeeburg EJ, Cereda MG, van Velthoven ME, Faridpooya K, Vermeer KA, et al. Intravitreal versus subretinal administration of recombinant tissue plasminogen activator combined with gas for acute submacular hemorrhages due to age-related macular degeneration: an exploratory prospective study. Retina. 2016;36(5):914–25.

Article  Google Scholar 

Kitagawa Y, Shimada H, Mori R, Tanaka K, Yuzawa M. Intravitreal tissue plasminogen activator, ranibizumab, and gas injection for submacular hemorrhage in polypoidal choroidal vasculopathy. Ophthalmology. 2016;123(6):1278–86.

Article  Google Scholar 

Schulze SD, Hesse L. Tissue plasminogen activator plus gas injection in patients with subretinal hemorrhage caused by age-related macular degeneration: predictive variables for visual outcome. Graefes Arch Clin Exp Ophthalmol. 2002;240(9):717–20.

Article  CAS  Google Scholar 

Hirashima T, Moriya T, Bun T, Utsumi T, Hirose M, Oh H. Optical coherence tomography findings and surgical outcomes of tissue plasminogen activator-assisted vitrectomy for submacular hemorrhage secondary to age-related macular degeneration. Retina. 2015;35(10):1969–78.

Article  CAS  Google Scholar 

Olivier S, Chow DR, Packo KH, MacCumber MW, Awh CC. Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in age-related macular degeneration. Ophthalmology. 2004;111(6):1201–8.

Article  Google Scholar 

Kadonosono K, Arakawa A, Yamane S, Inoue M, Yamakawa T, Uchio E, et al. Displacement of submacular hemorrhages in age-related macular degeneration with subretinal tissue plasminogen activator and air. Ophthalmology. 2015;122(1):123–8.

Article  Google Scholar 

Fine HF, Iranmanesh R, Del Priore LV, Barile GR, Chang LK, Chang S, et al. Surgical outcomes after massive subretinal hemorrhage secondary to age-related macular degeneration. Retina. 2010;30(10):1588–94.

Article  Google Scholar 

Sharma S, Kumar JB, Kim JE, Thordsen J, Dayani P, Ober M, et al. Pneumatic displacement of submacular hemorrhage with subretinal air and tissue plasminogen activator: initial United States experience. Ophthalmol Retina. 2018;2(3):180–6.

Article  Google Scholar 

Treumer F, Klatt C, Roider J, Hillenkamp J. Subretinal coapplication of recombinant tissue plasminogen activator and bevacizumab for neovascular age-related macular degeneration with submacular haemorrhage. Br J Ophthalmol. 2010;94(1):48–53.

Article  CAS  Google Scholar 

Inoue M, Shiraga F, Shirakata Y, Morizane Y, Kimura S, Hirakata A. Subretinal injection of recombinant tissue plasminogen activator for submacular hemorrhage associated with ruptured retinal arterial macroaneurysm. Graefes Arch Clin Exp Ophthalmol. 2015;253(10):1663–9.

Article  CAS  Google Scholar 

Zhao XY, Luo MY, Meng LH, Zhang WF, Li B, Wang EQ, et al. The incidence, characteristics, management, prognosis, and classification of breakthrough vitreous hemorrhage secondary to polypoidal choroidal vasculopathy. Retina. 2021;41(8):1675–85.

Article  CAS  Google Scholar 

留言 (0)

沒有登入
gif